Bioventus Inc (NASDAQ: BVS) is 73.06% higher on its value in year-to-date trading and has touched a low of $2.82 and a high of $8.68 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BVS stock was last observed hovering at around $8.20 in the last trading session, with the day’s gains setting it 0.92%.
Currently trading at $9.12, the stock is 20.53% and 34.02% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.97 million and changing 11.22% at the moment leaves the stock 69.52% off its SMA200. BVS registered 126.58% gain for a year compared to 6-month gain of 107.74%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 20.63% loss in the last 1 month and extending the period to 3 months gives it a 48.05%, and is 14.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.97% over the week and 6.89% over the month.
Bioventus Inc (BVS) has around 970 employees, a market worth around $594.53M and $536.89M in sales. Fwd P/E is 15.64. Profit margin for the company is -7.82%. Distance from 52-week low is 223.24% and 5.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-8.32%).
The EPS is expected to grow by 1828.37% this year
130.0 institutions hold shares in Bioventus Inc (BVS), with institutional investors hold 73.94% of the company’s shares. The shares outstanding are 63.27M, and float is at 40.19M with Short Float at 4.30%. Institutions hold 65.43% of the Float.
The top institutional shareholder in the company is ESSEX WOODLANDS MANAGEMENT, INC. with over 13.02 million shares valued at $67.71 million. The investor’s holdings represent 20.785 of the BVS Shares outstanding. As of 2024-03-31, the second largest holder is JUNIPER INVESTMENT COMPANY, LLC with 6.83 million shares valued at $35.54 million to account for 10.9084 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 5.81 million shares representing 9.2677 and valued at over $30.19 million, while VANGUARD GROUP INC holds 1.945 of the shares totaling 1.22 million with a market value of $6.34 million.
Bioventus Inc (BVS) Insider Activity
The most recent transaction is an insider purchase by Bartholdson John A., the company’s Director. SEC filings show that Bartholdson John A. bought 80,000 shares of the company’s common stock on Aug 16 ’24 at a price of $8.55 per share for a total of $0.68 million. Following the purchase, the insider now owns 6.91 million shares.
Bioventus Inc disclosed in a document filed with the SEC on Aug 19 ’24 that Bartholdson John A. (Director) bought a total of 25,500 shares of the company’s common stock. The trade occurred on Aug 19 ’24 and was made at $8.55 per share for $0.22 million. Following the transaction, the insider now directly holds 6.94 million shares of the BVS stock.
Still, SEC filings show that on Jun 21 ’24, Singleton Mark Leonard (SVP & CFO) disposed off 9,219 shares at an average price of $5.57 for $51350.0. The insider now directly holds 84,895 shares of Bioventus Inc (BVS).
